SEATTLE--(BUSINESS WIRE)--MitoPharm Corporation, Inc. (Pink Sheets:MTPM), announced today that its newly discovered compound Schisandrin B is an excellent candidate as a remedy for stamina and exercise-performance improvement. MitoPharm believes that its products have the potential to play a significant role in addressing the aging concerns of the baby boomers, the heart-health and heart-diseases markets, and the segment of the population that is physically active.
